Similar articles for PMID: 18675332

Year	Number of Results
2001	1
2003	1
2004	1
2005	2
2006	4
2007	7
2008	28
2009	32
2014	2
2016	1
2024	0

1

Proteomic analysis of human breast cell lines using SELDI-TOF MS shows that mixtures of estrogenic compounds exhibit simple similar action (concentration additivity).

Zhu Z, Edwards RJ, Boobis AR. Zhu Z, et al. Toxicol Lett. 2008 Sep 26;181(2):93-103. doi: 10.1016/j.toxlet.2008.07.006. Epub 2008 Jul 15. Toxicol Lett. 2008. PMID: 18675332

2

A proteomic (SELDI-TOF-MS) approach to estrogen agonist screening.

Walker CC, Salinas KA, Harris PS, Wilkinson SS, Watts JD, Hemmer MJ. Walker CC, et al. Toxicol Sci. 2007 Jan;95(1):74-81. doi: 10.1093/toxsci/kfl079. Epub 2006 Aug 17. Toxicol Sci. 2007. PMID: 16917070

3

A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment.

Le Moguen K, Lincet H, Marcelo P, Lemoisson E, Heutte N, Duval M, Poulain L, Vinh J, Gauduchon P, Baudin B. Le Moguen K, et al. Proteomics. 2007 Nov;7(22):4090-101. doi: 10.1002/pmic.200700231. Proteomics. 2007. PMID: 17994630

4

Proteomic analysis of MCF-7 breast cancer cell line exposed to mitogenic concentration of 17beta-estradiol.

Malorni L, Cacace G, Cuccurullo M, Pocsfalvi G, Chambery A, Farina A, Di Maro A, Parente A, Malorni A. Malorni L, et al. Proteomics. 2006 Nov;6(22):5973-82. doi: 10.1002/pmic.200600333. Proteomics. 2006. PMID: 17051647

5

Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cells.

Dowling P, Maurya P, Meleady P, Glynn SA, Dowd AJ, Henry M, Clynes M. Dowling P, et al. Anticancer Res. 2007 May-Jun;27(3A):1309-17. Anticancer Res. 2007. PMID: 17593624 Free article.

6

Effects of the endocrine disruptors atrazine and PCB 153 on the protein expression of MCF-7 human cells.

Lasserre JP, Fack F, Revets D, Planchon S, Renaut J, Hoffmann L, Gutleb AC, Muller CP, Bohn T. Lasserre JP, et al. J Proteome Res. 2009 Dec;8(12):5485-96. doi: 10.1021/pr900480f. J Proteome Res. 2009. PMID: 19778091

7

The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.

Cadron I, Van Gorp T, Amant F, Vergote I, Moerman P, Waelkens E, Daemen A, Van De Plas R, De Moor B, Zeillinger R. Cadron I, et al. Anticancer Res. 2009 Apr;29(4):1039-45. Anticancer Res. 2009. PMID: 19414343 Free article.

8

Clinical proteomics in breast cancer: a review.

Gast MC, Schellens JH, Beijnen JH. Gast MC, et al. Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Breast Cancer Res Treat. 2009. PMID: 19082706 Review.

9

Increased expression of histone proteins during estrogen-mediated cell proliferation.

Zhu Z, Edwards RJ, Boobis AR. Zhu Z, et al. Environ Health Perspect. 2009 Jun;117(6):928-34. doi: 10.1289/ehp.0800109. Epub 2009 Feb 7. Environ Health Perspect. 2009. PMID: 19590685 Free PMC article.

10

Identification of estrogen-responsive proteins in MCF-7 human breast cancer cells using label-free quantitative proteomics.

Zhu Z, Boobis AR, Edwards RJ. Zhu Z, et al. Proteomics. 2008 May;8(10):1987-2005. doi: 10.1002/pmic.200700901. Proteomics. 2008. PMID: 18491314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

68 results

Results by year